Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

G Assmann1, H Schulte, A von Eckardstein

  • 1Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany.

Insights

This study identified serum triglycerides and lipoprotein(a) [Lp(a)] as significant, independent risk factors for major coronary events in men. These findings add to established cardiovascular risk factors, improving risk prediction for heart disease.

Area of Science:

  • Cardiology
  • Epidemiology
  • Biochemistry

Background:

  • Cardiovascular diseases remain a leading cause of mortality globally.
  • Identifying novel and independent risk factors is crucial for effective prevention strategies.
  • The Prospective Cardiovascular Münster Study (PROCAM) provides a robust dataset for investigating cardiovascular risk.

Purpose of the Study:

  • To analyze cardiovascular risk factors in a large cohort of middle-aged men.
  • To investigate the independent association of serum triglycerides and lipoprotein(a) [Lp(a)] with major coronary events.
  • To enhance the understanding of predictors for myocardial infarction and sudden cardiac death.

Main Methods:

  • Analysis of data from 4,849 male participants aged 40-65 years over an 8-year follow-up period.
  • Multiple logistic regression analysis to identify significant cardiovascular risk factors.
  • Subgroup analysis of 878 men to assess the association between lipoprotein(a) [Lp(a)] levels and coronary events.

Main Results:

  • Established risk factors including age, LDL cholesterol, HDL cholesterol, systolic blood pressure, smoking, diabetes, angina, and family history were confirmed.
  • Serum triglyceride levels showed a significant and independent association with the incidence of major coronary events.
  • Significantly higher geometric mean levels of lipoprotein(a) [Lp(a)] were observed in men who experienced major coronary events compared to those who did not.

Conclusions:

  • Serum triglyceride levels are sensitive indicators of increased risk for major coronary events.
  • Lipoprotein(a) [Lp(a)] levels are also sensitive indicators of increased risk for major coronary events.
  • These findings contribute to a more comprehensive assessment of cardiovascular risk beyond traditional factors.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...